Chinese Journal of Tissue Engineering Research ›› 2018, Vol. 22 ›› Issue (25): 4059-4064.doi: 10.3969/j.issn.2095-4344.0928

Previous Articles     Next Articles

Left ventricular transplantation of human umbilical cord blood mononuclear cells in the treatment of cerebral hemorrhage in rats: micro PET-CT evaluation and therapeutic mechanism

Wei Lin-huan1, Yao Xing-yu2, Zhang Guo-hua3, Yang Li-min4, Li Jian-bo3, Liu Jie3, Jin Na1, Duan Rui1   

  1. 1Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China; 2Hulunbeier Zhongmeng Hospital, Hulunbeier 021400, Inner Mongolia Autonomous Region, China; 3Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China; 4Experimental Center for Pathogenic Microorganisms and Immunity, Basic Medical School of Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
  • Revised:2018-03-28 Online:2018-09-08 Published:2018-09-08
  • Contact: Zhang Guo-hua, Chief physician, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010010, Inner Mongolia Autonomous Region, China
  • About author:Wei Lin-huan, Master candidate, Inner Mongolia Medical University, Hohhot 010059, Inner Mongolia Autonomous Region, China
  • Supported by:

    the National Natural Science Foundation of China, No. 81360189

Abstract:

BACKGROUND: In recent years, new stem cell transplantation therapies for cerebral hemorrhage have emerged, but little is reported on human umbilical cord blood mononuclear cells (HUCB-MNCs), especially on micro PET-CT evaluation of HUCB-MNCs effects.
OBJECTIVE: To evaluate the therapeutic effect of HUCB-MNCs in a rat model of cerebral hemorrhage by Longa and micro PET-CT and to explore the therapeutic mechanism.
METHODS: Models of cerebral hemorrhage were established in rats using secondary blood injection/needle retraction method. The rats in the experimental group were treated with HUCB-MNCs via left ventricular transplantation, and those in the control group received no treatment. Before and after transplantation (3, 7, 14, 21 days), the rats in the two groups were evaluated using Longa 5 scores and micro PET-CT images. ELISA was used to detect the level of angiotensin 1 in the brain homogenate.
RESULTS AND CONCLUSION: Longa 5 scores in the two groups were gradually decreased with time (P < 0.05). Compared with the control group, the Longa 5 scores in the experimental group decreased more significantly (P < 0.05). The standard absorption value (SUV%) in the center of hematoma and perihematomal region increased gradually in the two groups at 7, 14, 21 days after transplantation, but it was significantly higher in the experimental group than the control group (P < 0.05). The volume of hematoma and surrounding tissues was gradually reduced in the two groups, especially in the experimental group, at 7, 14, 21 days after transplantation (P < 0.05). The level of angiotensin 1 in the control group increased gradually with time (P < 0.05), while the level of angiotensin 1 in the experimental group gradually increased, peaked at 14 days and then reduced at 21 days after transplantation (P < 0.05). The level of angiotensin 1 was higher in the experimental group than the control group (P < 0.05). Overall, these findings reveal that HUCB-MNCs via left ventricular transplantation can improve neurologic function of rats, reduce hematoma, recover hematoma metabolism, and increase the level of angiotensin 1 in the rat brain, indicating that HUCB-MNCs transplantation can promote the repair of cerebral hemorrhage through neo-angiogenesis regulation.

中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程

Key words: Cerebral Hemorrhage, Cord Blood Stem Cell Transplantation, Tissue Engineering

CLC Number: